Missing/wrong data?
Log in to edit
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando
scientific article published on 28 September 2014
Author/s
author: Fabio Puglisi, Javier Cortes, Eva M Ciruelos, Michelino De Laurentiis, Joseph Gligorov
Work details
Publication date
September 28, 2014
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.